title: Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease.
abstract: Chronic kidney disease (CKD) is associated with a decline in muscle mass, strength, and function, collectively called "sarcopenia." Sarcopenia is associated with hospitalizations and mortality in CKD and is therefore important to understand and characterize. While the focus of skeletal health in CKD has traditionally focused on bone and mineral aberrations, it is now recognized that sarcopenia must also play a role in poor musculoskeletal health in this population. In this paper, we present an overview of skeletal muscle changes in CKD, including defects in skeletal muscle catabolism and anabolism in uremic tissue. There are many gaps in knowledge in this field that should be the focus for future research to unravel pathogenesis and therapies for musculoskeletal health in CKD.
authors.affiliation: Indiana University School of Health and Rehabilitation Sciences, Indianapolis, IN, 46202, USA.
authors.forename: Keith G
authors.initials: KG
authors.lastname: Avin
authors.forename: Ranjani N
authors.initials: RN
authors.lastname: Moorthi
mesh_terms: D000058:Accidental Falls / Q000517:prevention & control; D000818:Animals; D001842:Bone and Bones / Q000503:physiopathology*; D004185:Disability Evaluation; D004195:Disease Models, Animal; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D024510:Muscle Development / Q000502:physiology; D018482:Muscle, Skeletal / Q000503:physiopathology*; D055435:Myostatin / Q000502:physiology; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000503:physiopathology*; D055948:Sarcopenia / Q000209:etiology* / Q000503:physiopathology
chemical_list: D055435:Myostatin